Until President Trump suggested that hydroxychloroquine (HCQ, Plaquenil™) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS).
TUCSON, Ariz., June 17, 2020 /PRNewswire/ -- Until President Trump suggested that hydroxychloroquine (HCQ, Plaquenil™) might help COVID-19 patients, it was generally considered a very safe drug, observes the Association of American Physicians & Surgeons (AAPS). It was approved by the FDA in 1955 and has been used by hundreds of millions of patients worldwide for malaria, lupus, and rheumatoid arthritis. Physicians do not generally require an electrocardiogram before prescribing it. Apparently because of alarming media coverage, many patients are now expressing fear that HCQ is dangerous because of cardiac effects, states AAPS. Outgoing AMA president Patrice Harris, M.D., told the media that “you could lose your life.” Widely reported studies have been stopped because of lack of benefit in seriously ill hospitalized COVID-19 patients and the occurrence of cardiac rhythm disturbances. AAPS notes the following:
Americans are being urged to “follow the science.” But AAPS asks: “How can we trust the established authorities or prestigious journals when, in this perilous time, trials of an available, inexpensive, long-established drug appear to be designed to fail, while risking the lives of their subjects through deliberate or negligent drug overdoses?” The Association of American Physicians and Surgeons (AAPS) has represented physicians of all specialties in all states since 1943. The AAPS motto is omnia pro aegroto, meaning everything for the patient. View original content to download multimedia:http://www.prnewswire.com/news-releases/researchers-overdosing-covid-19-patients-on-hydroxychloroquine-states-association-of-american-physicians--surgeons-aaps-301078986.html SOURCE Association of American Physicians and Surgeons (AAPS) |